Status:
COMPLETED
Evaluation of Diagnostic HIV Ag/Ab Combo Assay
Lead Sponsor:
Abbott Diagnostics Division
Conditions:
Human Immunodeficiency Viruses
Eligibility:
All Genders
Phase:
PHASE3
Brief Summary
To test blood specimens using a new investigational test that detects antigen and antibody to human immunodeficiency virus (HIV). Results will be compared to an approved HIV antibody test and suppleme...
Detailed Description
All specimens collected under separate specimen collection protocols or obtained from specimen suppliers will be provided to the clinical sites performing the investigational HIV test. This includes ...
Eligibility Criteria
Inclusion
- Normal Healthy Population:
- Apparently healthy individual at the time of enrollment as affirmed by the subject
Exclusion
- HIV infection as affirmed by the subject
- Pregnant Female Population at Risk for HIV Infection:
- Inclusion Criteria:
- Subject is a pregnant female
- Subject has risk factor for HIV infection
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2009
Estimated Enrollment :
635 Patients enrolled
Trial Details
Trial ID
NCT00933933
Start Date
June 1 2009
End Date
November 1 2009
Last Update
July 12 2011
Active Locations (13)
Enter a location and click search to find clinical trials sorted by distance.
1
Radiant Research
Phoenix, Arizona, United States, 85013
2
Pinellas County Health Dept, Florida Department of Health
St. Petersburg, Florida, United States, 33701
3
Springfield Clinic, LLP
Springfield, Illinois, United States, 62703
4
Minneapolis Medical Research Foundation
Minneapolis, Minnesota, United States, 55404